Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elonide versus Nasonex for perennial allergic rhinitis
TCTR20180828010Phase 2Active, not recruiting
- Sponsor
- Hoe Pharmaceuticals Sdn. Bhd.
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mometasone furoate nasal spray, mometasone in perennial rhinitis, sponsored by Hoe Pharmaceuticals Sdn. Bhd.. Started Sep 2018; status: active, not recruiting.
02
Drugs
mometasone furoate nasal spraymometasone
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on TCTR20180828010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180828010.